Ping Ai
Hubei University of Medicine(CN)Sichuan University(CN)Sichuan Cancer Hospital(CN)
Publications by Year
Research Areas
Head and Neck Cancer Studies, Lung Cancer Research Studies, Lung Cancer Treatments and Mutations, Glioma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial(2016)937 cited
- → Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long‐term results of phase 3 randomized controlled trial(2019)244 cited
- → Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial(2024)150 cited
- → Malignant Pleural Effusion and ascites Induce Epithelial-Mesenchymal Transition and Cancer Stem-like Cell Properties via the Vascular Endothelial Growth Factor (VEGF)/Phosphatidylinositol 3-Kinase (PI3K)/Akt/Mechanistic Target of Rapamycin (mTOR) Pathway(2016)33 cited
- → Comparison of GP and TPF induction chemotherapy for locally advanced nasopharyngeal carcinoma(2019)32 cited